Cancer biomarker, diagnostic methods, and assay reagents
OwnerReuben S. Harris, Michael Burns +1inventors
InventorsREUBEN S. HARRIS, Michael Burns, Eric W. Refsland
Life of this patent
Estimating the term…
Loading patent…
OwnerReuben S. Harris, Michael Burns +1inventors
InventorsREUBEN S. HARRIS, Michael Burns, Eric W. Refsland
Estimating the term…
This disclosure describes APOBEC3B as a biomarker for certain cancers such as, for example, breast cancer. This disclosure therefore describes methods for detecting APOBEC3B in a biological sample. The methods generally include measuring expression of APOBEC3B in a biological sample obtained from a patient and identifying the patient as having or at risk for having cancer if the measured expression of APOBEC3B is greater than a predetermined reference level of expression. This disclosure also describes isolated polynucleotides that may be used as reagents in methods for detecting and/or measuring APOBEC3B expression.
A method comprising:
An isolated polynucleotide comprising the nucleotide sequence of SEQ ID NO:12.
An isolated polynucleotide comprising the nucleotide sequence of SEQ ID NO:24.
A kit comprising in separate containers:
A method comprising:
Dependencies are inferred from the claim text.